Parke-davis Company Profile
✉ Email this page to a colleague
What is the competitive landscape for PARKE-DAVIS, and what generic and branded alternatives to PARKE-DAVIS drugs are available?
PARKE-DAVIS has one approved drug.
Summary for Parke-davis
| US Patents: | 0 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Parke-davis
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Parke-davis | ZARONTIN | ethosuximide | SYRUP;ORAL | 080258-001 | Approved Prior to Jan 1, 1982 | AA | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
